Ryan Specialty Holdings (RYAN) Cash & Equivalents (2020 - 2026)

Ryan Specialty Holdings (RYAN) has 7 years of Cash & Equivalents data on file, last reported at $154.6 million in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $154.6 million, down 24.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $154.6 million (down 24.02% YoY), and the FY2025 annual result was $158.3 million, down 70.69% from the prior year.
• Cash & Equivalents slipped to $154.6 million in Q1 2026 per RYAN's latest filing, from $158.3 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $2.0 billion in Q2 2023 and troughed at $153.5 million in Q3 2025.
• A 5-year average of $896.2 million and a median of $754.4 million in 2023 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2022 and 2025: Cash & Equivalents surged 103.17% in 2022, then slumped 87.45% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $1.8 billion in 2022, then slumped by 52.54% to $838.8 million in 2023, then plunged by 35.6% to $540.2 million in 2024, then sank by 70.69% to $158.3 million in 2025, then retreated by 2.32% to $154.6 million in 2026.
• Business Quant data shows RYAN's Cash & Equivalents at $154.6 million in Q1 2026, $158.3 million in Q4 2025, and $153.5 million in Q3 2025.